Paid Clinical Trials in Texas

Texas has 5,344 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,652 clinical trials

Get a weekly email when new trials open in Houston, TX.

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

for Renal Transplant Failure and Rejection

Sites in Dallas +6 more locations

Sponsor: Nefro Avillion Clinical Development, LLC

Sex: All·Age: 18 - 70

Code: NCT07508787·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

for Myotonic Dystrophy Type 1 (DM1)

Sites in San Antonio +9 more locations

Sponsor: Dyne Therapeutics

Sex: All·Age: 16+

Code: NCT07486934·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

for Solid Malignancies

Sites in Houston +3 more locations

Sponsor: Immunome, Inc.

Sex: All·Age: 18+

Code: NCT07505771·EARLY_Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

for Acute Promyelocytic Leukemia (APL)

Sites in Houston +13 more locations

Sponsor: Quetzal Therapeutics

Sex: All·Age: 18 - 71

Code: NCT07504458·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

for Relapsed or Refractory Large B-cell Lymphoma

Sites in Austin +13 more locations

Sponsor: Kite, A Gilead Company

Sex: All·Age: 18+

Code: NCT07479797·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

for Chronic Pain

Sites in Houston, San Antonio +3 more locations

Sponsor: Medtronic

Sex: All·Age: 18+

Code: NCT07507422·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

for Muscle-invasive Bladder Cancer

Sites in San Antonio +11 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07475806·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A 2-part Phase 1/2 Open-label Trial on ODM-212

for Mesothelioma

Sites in Irving +1 more location

Sponsor: Orion Corporation, Orion Pharma

Sex: All·Age: 18+

Code: NCT07563738·Phase 1, Phase 2·Recruiting·Listed May 2026

Apply to this trial

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

for Epidermal Growth Factor

Sites in Houston, San Antonio +4 more locations

Sponsor: EpiBiologics

Sex: All·Age: 18+

Code: NCT07462377·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

for Venous Thromboembolism (VTE)

Sites in El Paso +2 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07493304·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

for Urge Urinary Incontinence

Sites in Arlington +12 more locations

Sponsor: MedtronicNeuro

Sex: All·Age: 18+

Code: NCT07456865·Recruiting·Listed Mar 2026

Apply to this trial

Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

for Erythropoietic Protoporphyria (EPP)

Sites in Houston +4 more locations

Sponsor: Portal Therapeutics, Inc.

Sex: All·Age: 12+

Code: NCT07567131·Recruiting·Listed May 2026

Apply to this trial

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

for Neurological Disorder

Sites in Dallas +4 more locations

Sponsor: Synchron, Inc.

Sex: All·Age: 22+

Code: NCT07543367·Recruiting·Listed Apr 2026

Apply to this trial

Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia

for Achondroplasia

Drug: Vosoritide

Sites in Houston, Dallas +7 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: 2 - 17

Code: NCT07441876·Phase 2, Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

for Bladder (Urothelial, Transitional Cell) Cancer

Sites in Houston, Arlington +6 more locations

Sponsor: Protara Therapeutics

Sex: All·Age: 18+

Code: NCT07480356·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

for Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Sites in Dallas +5 more locations

Sponsor: TORL Biotherapeutics, LLC

Sex: All·Age: 18+

Code: NCT07439653·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

for Polycythemia Vera (PV)

Sites in Houston +7 more locations

Sponsor: Prelude Therapeutics Incorporated

Sex: All·Age: 18+

Code: NCT07469891·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for Solid Tumor

Sites in Fort Worth +2 more locations

Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07517198·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

for Atopic Dermatitis (AD)

Sites in San Antonio, College Station +3 more locations

Sponsor: Arcutis Biotherapeutics, Inc.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07453602·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.

for KRAS P.G12D

Sites in Houston, San Antonio +1 more location

Sponsor: D3 Bio (Wuxi) Co., Ltd

Sex: All·Age: 18+

Code: NCT07456046·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)

for Angiokeratomas

Sites in Southlake +3 more locations

Sponsor: Palvella Therapeutics, Inc.

Sex: All·Age: 6+

Code: NCT07552077·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

Sites in Houston, Austin +14 more locations

Sponsor: BioNTech SE

Sex: Male·Age: 18+

Code: NCT07365995·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.

for COVID -19

Sites in Austin +1 more location

Sponsor: ModeX Therapeutics, An OPKO Health Company

Sex: All·Age: 18 - 64·Accepts healthy volunteers

Code: NCT07445971·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients

for Known or Highly Suspected Central Nervous System (CNS) Lesion

Sites in The Woodlands +1 more location

Sponsor: GE Healthcare

Sex: All·Age: 18+

Code: NCT07472491·Phase 2, Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

for Von Hippel-Lindau Disease

Sites in San Antonio +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07405164·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Study of ALK-001 on the Progression of Stargardt Disease

for Stargardt Disease

Sites in Dallas, San Antonio +8 more locations

Sponsor: Alkeus Pharmaceuticals, Inc.

Sex: All·Age: 8 - 45

Code: NCT07419334·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of GEN1106 in Participants With Solid Tumors

for Solid Tumors

Sites in San Antonio +4 more locations

Sponsor: Genmab

Sex: All·Age: 18+

Code: NCT07416123·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

for Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)

Sites in Irving +6 more locations

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07403721·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Clareon TruPlus Study

for Aphakia

Sites in Sugar Land +4 more locations

Sponsor: Alcon Research

Sex: All·Age: 22+

Code: NCT07502456·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

for Chronic Inducible Urticaria

1 location in San Antonio

Sponsor: Enanta Pharmaceuticals, Inc

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07540910·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

ROME GS System Study

for Diabetes

Sites in San Antonio +3 more locations

Sponsor: Senseonics, Inc.

Sex: All·Age: 18+

Code: NCT07518004·Recruiting·Listed Apr 2026

Apply to this trial

Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

for Netherton Syndrome

Sites in San Antonio +4 more locations

Sponsor: Quoin Pharmaceuticals

Sex: All·Age: 4+

Code: NCT07538583·Phase 2, Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

for T Cell Malignancies

Sites in Houston +5 more locations

Sponsor: Electra Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT07465835·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)

for Dilated Cardiomyopathy (DCM)

Sites in Houston +2 more locations

Sponsor: Affinia Therapeutics

Sex: All·Age: 18 - 70

Code: NCT07426419·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

for Prostate Cancer

Sites in San Antonio +3 more locations

Sponsor: Francis Medical Inc.

Sex: Male·Age: All ages

Code: NCT07455058·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

for Multiple Myeloma (MM)

Drug: HLX15

Sites in Houston +8 more locations

Sponsor: Shanghai Henlius Biotech

Sex: All·Age: 18+

Code: NCT07477587·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

for Cancer-Associated Thrombosis (CAT)

Sites in El Paso +2 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07410117·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

for Advanced Solid Tumors

Drug: Ivonescimab

Sites in Houston, San Antonio +7 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07397338·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Sites in Fort Worth +1 more location

Sponsor: iLeukon Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07452224·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis

for Primary Sclerosing Cholangitis

Drug: Elafibranor

Sites in Houston, San Antonio +11 more locations

Sponsor: Ipsen

Sex: All·Age: 18 - 75

Code: NCT07387549·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial